Literature DB >> 12370411

Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides.

Chikara Ohyama1, Satoru Kanto, Kazunori Kato, Osamu Nakano, Yoichi Arai, Tetsuro Kato, Shihao Chen, Michiko N Fukuda, Minoru Fukuda.   

Abstract

Epithelial carcinoma and leukemia cells express sialyl Lewis x oligosaccharides as tumor-associated carbohydrate antigens. To determine the role of sialyl Lewis x oligosaccharides in tumor dissemination, human melanoma MeWo cells, which do not express sialyl Lewis x, were transfected with alpha1,3-fucosyltransferase III (FTIII), and cell lines expressing different amounts of sialyl Lewis x were isolated. When these cells were injected into the tail vein of nude mice, cells expressing moderate amounts of sialyl Lewis x (MeWo-FTIII.M) produced a significantly greater number of lung tumor foci than did parental MeWo cells. In contrast, cells expressing large amounts of sialyl Lewis x (MeWo-FTIII.H) produced few lung tumor foci in nude mice but were highly tumorigenic in beige mice, which have defective natural killer (NK) cells. In vitro assays demonstrated that MeWo-FTIII.H cells are much more sensitive to NK cell-mediated cytotoxicity than are MeWo-FTIII.M cells or parental MeWo cells and the susceptibility of MeWo-FTIII.H cells to NK cell-mediated cytolysis can be inhibited by preincubating MeWo-FTIII.H cells with anti-sialyl Lewis x antibody. Moreover, we discovered that NK cell-mediated cytolysis of MeWo-FTIII.H cells can be inhibited by the addition of an antibody against the NK cell receptor CD94 or sialyl Lewis x oligosaccharides. These results, combined with structural analysis of MeWo-FTIII.H cell carbohydrates, indicate that moderate amounts of sialyl Lewis x lead to tumor metastasis, whereas expression of high levels of sialyl Lewis x leads to an NK cell attack on tumor cells, demonstrating that expression of different amounts of sialyl Lewis x results in entirely different biological consequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370411      PMCID: PMC129776          DOI: 10.1073/pnas.212456599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  On guard--activating NK cell receptors.

Authors:  L L Lanier
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

2.  A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells.

Authors:  M N Fukuda; C Ohyama; K Lowitz; O Matsuo; R Pasqualini; E Ruoslahti; M Fukuda
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

3.  Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes.

Authors:  S Hemmerich; A Bistrup; M S Singer; A van Zante; J K Lee; D Tsay; M Peters; J L Carminati; T J Brennan; K Carver-Moore; M Leviten; M E Fuentes; N H Ruddle; S D Rosen
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

4.  CD27-mediated activation of murine NK cells.

Authors:  K Takeda; H Oshima; Y Hayakawa; H Akiba; M Atsuta; T Kobata; K Kobayashi; M Ito; H Yagita; K Okumura
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

5.  Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase.

Authors:  J C Yeh; N Hiraoka; B Petryniak; J Nakayama; L G Ellies; D Rabuka; O Hindsgaul; J D Marth; J B Lowe; M Fukuda
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

6.  Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes.

Authors:  M Fukuda; E Spooncer; J E Oates; A Dell; J C Klock
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

7.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

8.  A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34.

Authors:  N Hiraoka; B Petryniak; J Nakayama; S Tsuboi; M Suzuki; J C Yeh; D Izawa; T Tanaka; M Miyasaka; J B Lowe; M Fukuda
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

9.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

Authors:  J L Magnani; B Nilsson; M Brockhaus; D Zopf; Z Steplewski; H Koprowski; V Ginsburg
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

10.  Sialyl Lewis X-dependent lung colonization of B16 melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin.

Authors:  Jianing Zhang; Jun Nakayama; Chikara Ohyama; Masami Suzuki; Atsushi Suzuki; Minoru Fukuda; Michiko N Fukuda
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more
  14 in total

1.  L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells.

Authors:  Dorota Hoja-Łukowicz; Paweł Link-Lenczowski; Andrea Carpentieri; Angela Amoresano; Ewa Pocheć; Konstantin A Artemenko; Jonas Bergquist; Anna Lityńska
Journal:  Glycoconj J       Date:  2012-04-29       Impact factor: 2.916

2.  Polymorphisms of Lewis and Secretor genes are related to breast cancer and metastasis in axillary lymph nodes.

Authors:  Debora Barreto Teresa; Raquel Alves Santos; Catarina Satie Takahashi; Helio H Carrara; Haroldo W Moreira; Luis Carlos Mattos; Nicolino Lia-Neto; Leonardo A Cunha; Carmem Lucia Bassi; Edson Garcia Soares; Eduardo Antonio Donadi; Elaine Rodrigues Mello; Christiane Pienna Soares
Journal:  Tumour Biol       Date:  2010-06-01

3.  Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.

Authors:  Thomas Kolben; Lena Müller; Sarah Meister; Lucia Keilmann; Christina Buschmann; Fabian Trillsch; Alexander Burges; Bastian Czogalla; Sophie Mitter; Elisa Schmoeckel; Stefanie Corradini; Sven Mahner; Udo Jeschke; Mirjana Kessler; Susanne Beyer
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-21       Impact factor: 4.322

Review 4.  The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins.

Authors:  Fanqi Jin; Fengshan Wang
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

5.  alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Authors:  Marta Pérez-Garay; Beatriz Arteta; Lluís Pagès; Rafael de Llorens; Carme de Bolòs; Fernando Vidal-Vanaclocha; Rosa Peracaula
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

6.  Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.

Authors:  Udo Jeschke; Ioannis Mylonas; Christiane Kunert-Keil; Renate Stahn; Christoph Scholz; Wolfgang Janni; Christina Kuhn; Eike Schröder; Doris Mayr; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2008-10-14       Impact factor: 4.304

Review 7.  Glycosylation in bladder cancer.

Authors:  Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

8.  The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation.

Authors:  Eric Lau; Yongmei Feng; Giuseppina Claps; Michiko N Fukuda; Ally Perlina; Dylan Donn; Lucia Jilaveanu; Harriet Kluger; Hudson H Freeze; Ze'ev A Ronai
Journal:  Sci Signal       Date:  2015-12-08       Impact factor: 8.192

9.  Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.

Authors:  David J Monsma; Noel R Monks; David M Cherba; Dawna Dylewski; Emily Eugster; Hailey Jahn; Sujata Srikanth; Stephanie B Scott; Patrick J Richardson; Robin E Everts; Aleksandr Ishkin; Yuri Nikolsky; James H Resau; Robert Sigler; Brian J Nickoloff; Craig P Webb
Journal:  J Transl Med       Date:  2012-06-18       Impact factor: 5.531

Review 10.  Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.

Authors:  Marco Trinchera; Adele Aronica; Fabio Dall'Olio
Journal:  Biology (Basel)       Date:  2017-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.